NCT00005673View on ClinicalTrials.gov

Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 31, 2000

Study Completion Date

May 31, 2002

Conditions
HealthyHIV Infection
Interventions
DRUG

Capravirine

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00005673 - Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs | Biotech Hunter | Biotech Hunter